Business Wire

MA-EVERBRIDGE

Share
Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), to be Special Guest Speaker at Everbridge COVID-19: Road to Recovery (R2R) Executive Summit, May 26-27, 2021

Everbridge , Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM ), today announced that Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), will provide a ‘special guest’ address for its Spring 2021 COVID-19: Road to Recovery (R2R) virtual leadership summit taking place this week, May 26-27, discussing business resiliency and civic leadership in a post-pandemic world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210524005267/en/

The two-day symposium, kicking off on Wednesday, May 26th , will also feature keynote addresses from world leaders including the 42nd President of the United States Bill Clinton , former United States Secretary of State Dr. Madeleine K. Albright , industry icons such as Chairman & Editor-In-Chief of Forbes Media Steve Forbes , as well as discussions with C-level business executives from Moderna, Volkswagen, Lululemon, Salesforce.com, the Centers for Disease Control and Prevention (CDC), and many others across industries and global markets.

As a specialized agency of the United Nations responsible for international public health, the WHO states its global mission as “the attainment by all peoples of the highest possible level of health.”

Elected WHO Director-General for a five-year term, Dr. Tedros Adhanom Ghebreyesus represents the first person from the WHO African Region to head the world’s leading public health agency. Dr. Tedros is an Ethiopian biologist, public health researcher, and official who has served since 2017.

Prior to his election as Director-General of WHO, Dr. Tedros held many leadership positions in global health, including as Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, Chair of the Roll Back Malaria Partnership, and Co-chair of the Partnership for Maternal, Newborn and Child Health Board.

“We welcome Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, to the Everbridge COVID-19: Road to Recovery Spring 2021 symposium,” said David Meredith, Chief Executive Officer, Everbridge. “We look forward to hearing his global perspective on the international response to the pandemic and the way forward, along with key post-pandemic insights from other C-level executives across industries and sectors.”

The Everbridge Spring 2021 COVID-19: Road to Recovery (R2R) Symposium will feature presentations from Dr. Judy Monroe, CDC Foundation President and Chief Executive Officer, and Dr. Jay C. Butler, CDC Deputy Director for Infectious Diseases (DDID), who will cover the current state of the pandemic, the coronavirus vaccine rollout and what to expect in the latest phase of the global crisis as life and business begin to recover.

The multi-year Everbridge symposium series offers global leaders a valuable forum to exchange best practices on how to protect people and business assets; build back and grow revenue streams; increase business resiliency; and mitigate potential threats like IT outages, cyber-attacks, natural disasters, and many other critical events. Speakers and participants represent all sectors of society from business and government, community organizations and advocacy groups, to science, medicine, transportation, sports & entertainment, and academia.

Last year, Everbridge welcomed President George W. Bush , Anthony Fauci, MD, Scott Gottlieb, MD, Dr. Sanjay Gupta, MD, U.S. General Colin L. Powell, USA (Ret.), and Virgin Group Founder Sir Richard Branson, among others, to serve as keynote speakers. The COVID-19: Road to Recovery (R2R) virtual leadership summits attracted more than 40,000 participants including government officials, healthcare experts and senior executives from 150 countries, as well as participants from the Centers for Disease Control and Prevention, the Mayo Clinic, Goldman Sachs, Fannie Mae, Ford Motor Company, Humana, IBM, and others.

To register for the Everbridge Spring 2021 COVID-19 R2R: The Road to Recovery Symposium, click here .

About Everbridge

Everbridge, Inc. (NASDAQ: EVBG) is a global software company that provides enterprise software applications that automate and accelerate organizations’ operational response to critical events in order to Keep People Safe and Organizations Running™. During public safety threats such as active shooter situations, terrorist attacks or severe weather conditions, as well as critical business events including IT outages, cyber-attacks or other incidents such as product recalls or supply-chain interruptions, over 5,700 global customers rely on the Company’s Critical Event Management Platform to quickly and reliably aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes through the secure delivery to over 100 different communication modalities, and track progress on executing response plans. Everbridge serves 8 of the 10 largest U.S. cities, 9 of the 10 largest U.S.-based investment banks, 47 of the 50 busiest North American airports, 9 of the 10 largest global consulting firms, 8 of the 10 largest global automakers, 9 of the 10 largest U.S.-based health care providers, and 7 of the 10 largest technology companies in the world. Everbridge is based in Boston with additional offices in 20 cities around the globe. For more information visit www.everbridge.com

Cautionary Language Concerning Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the anticipated opportunity and trends for growth in our critical communications and enterprise safety applications and our overall business, our market opportunity, our expectations regarding sales of our products, our goal to maintain market leadership and extend the markets in which we compete for customers, and anticipated impact on financial results. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond our control. Our actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the ability of our products and services to perform as intended and meet our customers’ expectations; our ability to successfully integrate businesses and assets that we may acquire; our ability to attract new customers and retain and increase sales to existing customers; our ability to increase sales of our Mass Notification application and/or ability to increase sales of our other applications; developments in the market for targeted and contextually relevant critical communications or the associated regulatory environment; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate; we have not been profitable on a consistent basis historically and may not achieve or maintain profitability in the future; the lengthy and unpredictable sales cycles for new customers; nature of our business exposes us to inherent liability risks; our ability to attract, integrate and retain qualified personnel; our ability to maintain successful relationships with our channel partners and technology partners; our ability to manage our growth effectively; our ability to respond to competitive pressures; potential liability related to privacy and security of personally identifiable information; our ability to protect our intellectual property rights, and the other risks detailed in our risk factors discussed in filings with the U.S. Securities and Exchange Commission (“SEC”), including but not limited to our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 26, 2021. The forward-looking statements included in this press release represent our views as of the date of this press release. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

All Everbridge products are trademarks of Everbridge, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Ras Al Khaimah Ruler Inaugurates 14th Ras Al Khaimah Art Festival21.1.2026 14:50:00 CET | Press release

The festival brings together more than 100 artists from 49 countriesIt is a leading cultural platform, celebrating artistic excellence, fostering international exchange and reinforcing the Emirate’s role as a host for cultural dialogue His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, inaugurated the 14th edition of Ras Al Khaimah Art Festival at Al Jazeera Al Hamra Heritage Village, marking the opening of the Emirate’s flagship annual cultural event. The festival is organized by the Sheikh Saud bin Saqr Al Qasimi Foundation for Policy Research and runs until February 8 under the theme ‘Civilizations’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121583855/en/ Ras Al Khaimah Art Festival, officially opened by His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, has successfully completed its opening weekend, where cultures

Duetti Secures $200 Million to Scale Independent Music Catalog Acquisitions and Enhance Platform Capabilities21.1.2026 14:01:00 CET | Press release

Funding Led by a $50 Million Series C Equity Investment from The Raine Group Duetti Inc. (“Duetti” or the “Company”), the music-tech and financial services company that empowers independent music creators to unlock the value of their music catalogs, today announces it has secured $200 million in new funding to accelerate music catalog acquisitions and expand its technology and services globally. The financing is led by a $50 million Series C equity investment by Raine Partners, the flagship growth equity fund of The Raine Group, alongside a second $125 million private securitization and a $25 million increase of an existing credit facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121033285/en/ In over three years, Duetti has raised over $635 million, including over $100 million in equity, to support the global independent music community. To date, the Company has partnered with more than 1,100 artists, songwriters,

Board Collaborates with Microsoft to Bring Agentic AI Into the Core of Enterprise Planning21.1.2026 14:00:00 CET | Press release

Domain-Specific, Enterprise-Ready AI Agents Support Continuous Planning Across Finance, Supply Chain and Merchandising Board, one of the leading Enterprise Planning Platforms, today announced the launch of Board Agents built on Microsoft Foundry. Board Agents deliver an intelligent suite of domain-specific, enterprise-ready AI agents that support real-world planning decisions across finance, supply chain, and merchandising. This marks the first Board enterprise planning capability developed with Microsoft Foundry, using Microsoft Azure’s agentic AI tools and services to accelerate secure, cloud-native AI innovation. The initial release includes FP&A and Controller Agents for the Office of Finance, with Merchandiser and Supply Chain Agents to follow. Board Agents are built natively into the Board Enterprise Planning Platform, providing a secure, governed foundation for applying agentic AI to high-impact planning use cases. “As interest in AI accelerates, many customers are looking for c

Copeland Advances AI and Digital Strategy with Acquisition of Bueno Analytics21.1.2026 13:00:00 CET | Press release

Acquisition integrates advanced SaaS capabilities to deliver smarter, data‑driven HVAC and cold chain solutions Copeland, a global provider of compression technologies and controls solutions, announced today that it has entered into an agreement to acquire Bueno Analytics (“Bueno”), an Australia-based company specializing in SaaS solutions that leverage embedded AI and machine learning to deliver building analytics, energy management and operational efficiency across commercial buildings and the cold chain. Bueno’s platform is deployed across several thousand customer sites worldwide, providing broad connectivity, full portfolio visibility and critical operational insights. Buildings account for an estimated 40% of global carbon emissions, with commercial buildings and the cold chain representing a significant share of that impact. The integration of Bueno’s platform with Copeland’s deep domain expertise will deliver a powerful suite of capabilities, including predictive maintenance, e

NIRSense, Inc. & Aspen Medical USA (AMUSA): Strengthening Frontline Medicine: U.S.–Developed Tissue Oxygenation Technology Delivered to Ukraine21.1.2026 13:00:00 CET | Press release

Today, NIRSense and Aspen Medical USA (AMUSA) are pleased to announce the donation of 12 portable tissue-ischemia monitoring kits (comprising advanced sensor consoles plus tablets) to the Ministry of Defence of Ukraine (MoD) for deployment in frontline Role-1 and Role-2 casualty care facilities in Ukraine. These investigational prototype systems are provided for use by military medical teams treating extremity-injured personnel (including those who have undergone tourniquet application) to assess and monitor tissue perfusion and oxygenation in real time. Why this matters In the battlefield context, timely recognition of compromised tissue perfusion (particularly in limbs subject to tourniquet use, major soft‐tissue injury or ischemia-reperfusion risk) can make the difference between viable salvage of the limb, avoidance of secondary complications, and optimal patient outcomes. The donated NIRSense kits, which will be administered by the Ukraine MoD under an approved protocol, may provi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye